Climate change has emerged as one of the most pressing global challenges of our time, with industries across the globe reevaluating their carbon footprints. For the pharmaceutical sector, particularly Active Pharmaceutical Ingredient (API) manufacturing, sustainability is no longer an option
Climate change is a real and undeniable threat to our entire civilization. The effects are already visible – rising temperatures, extreme weather events, melting glaciers, and biodiversity loss. If we do not act now, these changes will become catastrophic. Reducing
๐๐ ๐๐๐ง’๐ญ ๐๐๐๐ฎ๐๐ ๐๐ก๐๐ญ ๐๐ ๐๐จ๐ง’๐ญ ๐๐๐๐ฅ๐ข๐ณ๐ ๐๐ ๐๐ฌ๐ I have noticed we rarely think about how much electricity we use, until the bill arrives (๐ฑ). That’s when we start turning off unused lights, unplugging devices, and just being more
Introduction In an economy moving rapidly toward net-zero, businesses can no longer afford to consider sustainability as an option. Investors, stakeholders and regulators are increasingly focusing on transparency and credibility of organizations based on how they understand, measure, mitigate, and report
The climate crisis is at its tipping point. In order to mitigate emissions, we need to track them. Despite the growing necessity and want of small and medium-sized enterprises (SMEs) to lower emissions and drive tangible sustainable change, 90% feel restrained by the